ValtedSeq

Biotechnology ResearchMaryland, United States2-10 Employees

Valted Seq is a discovery-stage biopharmaceutical company rooted in neurodegenerative research, with leadership drawn from Johns Hopkins University scientists. The firm focuses on advancing single-cell level sequencing and developing diagnostic biomarker assays, aiming to illuminate neurodegenerative pathways and support the creation of precision therapeutics for diseases such as Alzheimer’s and Parkinson’s. Based in Gaithersburg, Maryland, the company operates within the biotechnology research sector and emphasizes collaboration with medical research institutions to drive innovations in healthcare.
Valted Seq positions itself in the life sciences ecosystem as part of the D&D Pharmatech/Neuraly family, reflecting a networked approach to translational neuroscience research. Its work targets researchers and clinicians seeking deeper molecular insights and reliable biomarker tools, addressing the challenges of understanding complex neurodegenerative biology. The company resides in a research-focused landscape near Gaithersburg and maintains a small-scale operation appropriate for a discovery-stage enterprise centered on scientific exploration and early-stage development.

Sign up for free to view info

Email Format Employee directory